VIR · Vir Biotechnology, Inc.
AI read · Neutral
The AI's read
His past finance leadership at Theravance and Gilead may help VIR manage its finances. The filing also sets out salary, bonus, sign-on pay, stock awards, and possible severance. It reports no change in business results, so these details do not clearly shift the company's outlook.